Drug Shortage Report for PROPOFOL INJECTION
Report ID | 43360 |
Drug Identification Number | 02244379 |
Brand name | PMS-PROPOFOL |
Common or Proper name | PROPOFOL |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | PROPOFOL |
Strength(s) | 10MG |
Dosage form(s) | EMULSION |
Route of administration | INTRAVENOUS |
Packaging size | 100ML |
ATC code | N01AX |
ATC description | ANESTHETICS, GENERAL |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2018-03-19 |
Estimated end date | Unknown |
Actual end date | 2020-06-09 |
Shortage status | Resolved |
Updated date | 2020-06-10 |
Company comments | Product to be discontinued. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-06-10 | French | Compare |
v4 | 2020-06-10 | English | Compare |
v3 | 2018-03-20 | English | Compare |
v2 | 2018-03-19 | French | Compare |
v1 | 2018-03-19 | English | Compare |
Showing 1 to 5 of 5